Cargando…

Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019

Detalles Bibliográficos
Autores principales:	Huang, Lan, Zhao, Xuan, Qi, Yu, Li, Hong, Ye, Guanchao, Liu, Yafei, Zhang, Yi, Gou, Jianjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484610/ https://www.ncbi.nlm.nih.gov/pubmed/32917983 http://dx.doi.org/10.1038/s41423-020-00522-6

Ejemplares similares

Etoposide for Cytokine Storm Because of Coronavirus Disease 2019
por: Delgado-López, Pedro David, et al.
Publicado: (2021)

Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19)
por: Cure, Erkan, et al.
Publicado: (2020)

The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019
por: Liu, Tao, et al.
Publicado: (2020)

Cytokine levels and pathological characteristics of a patient with severe coronavirus disease 2019: a case report
por: Kang, Kai, et al.
Publicado: (2022)

Ventricular Fibrillation Storm in Coronavirus 2019
por: Elsaid, Ossama, et al.
Publicado: (2020)

The role of a cytokine storm in severe coronavirus disease 2019 in pregnancy
por: Wang, Xiaoping, et al.
Publicado: (2020)

A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019
por: Zhang, Fengqin, et al.
Publicado: (2022)

Surveillance of endemic human Coronaviruses in Germany, 2019/2020
por: Biere, Barbara, et al.
Publicado: (2021)

Elevated interleukin‐6, interleukin‐10 and neutrophil : lymphocyte ratio as identifiers of severe coronavirus disease 2019
por: Godkin, Andrew, et al.
Publicado: (2020)

Famotidine and Coronavirus Disease 2019
por: Freedberg, Daniel E., et al.
Publicado: (2021)

Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma
por: Sgherza, Nicola, et al.
Publicado: (2021)

Interleukin-6 in Critical Coronavirus Disease 2019, a Driver of Lung Inflammation of Systemic Origin?
por: Aarskog, Nikolai Ravn, et al.
Publicado: (2021)

Famotidine and Mortality in Coronavirus Disease 2019
por: Sethia, Rahul, et al.
Publicado: (2021)

Asthma and prognosis of coronavirus disease 2019
por: Özdemir, Öner
Publicado: (2022)

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation
por: Salvatierra, Juan, et al.
Publicado: (2021)

Star in the storm: percutaneous stellate ganglion blockade for drug-refractory electrical storm in the emergency department
por: Bhattaram, Suhrith, et al.
Publicado: (2023)

Immune response after vaccination using inactivated vaccine for coronavirus disease 2019
por: Sun, Ya, et al.
Publicado: (2023)

Split-dosing of coronavirus disease 2019 vaccines
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

MicroCLOTS pathophysiology in coronavirus disease 2019
por: Renzi, Samuele, et al.
Publicado: (2023)

Individualizing dialysis dose under certain circumstances during the Severe Acute Respiratory Syndrome Coronavirus-2 (coronavirus disease 2019) pandemic: a perspective
por: Abdelaziz, Tarek Samy
Publicado: (2020)

Eliciting History of Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Diagnosing Interstitial Lung Disease during the Coronavirus Disease 2019 Pandemic
por: Stuewe, Elena, et al.
Publicado: (2021)

Surviving the storm: Dealing with COVID-19
por: Vandenbark, Arthur A., et al.
Publicado: (2020)

Prevention of the cytokine storm in COVID-19
por: Wright, David J M
Publicado: (2021)

A Non-severe Coronavirus Disease 2019 Patient With Persistently High Interleukin-6 Level
por: Hambali, Nurfarah Lydia, et al.
Publicado: (2020)

Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm
por: Shekhawat, Jyoti, et al.
Publicado: (2021)

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2021)

How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection?
por: Kloc, Malgorzata, et al.
Publicado: (2020)

Anti-Interleukins for Severe Coronavirus Disease-2019: Hype or Hope?
por: Dimosiari, Athina, et al.
Publicado: (2022)

Assessing the importance of interleukin-6 in COVID-19
por: Chen, Luke Y C, et al.
Publicado: (2021)

Pneumothorax in 2019 novel coronavirus pneumonia needs to be recognized
por: Li, Wenya, et al.
Publicado: (2020)

Coronavirus disease 2019 presenting with conjunctivitis as the first symptom
por: Casalino, Giuseppe, et al.
Publicado: (2020)

Management Issues of Sarcoidosis in the Time of Coronavirus Disease 2019
por: Tana, Claudio, et al.
Publicado: (2021)

What is the Determinant of 2019 Novel Coronavirus Prognosis in Children?
por: Yurttutan, Sadik
Publicado: (2000)

Zinc and Coronavirus Disease 2019: Causal or Casual Association?
por: Khurana, Alkesh Kumar, et al.
Publicado: (2021)

Exacerbation of livedoid vasculopathy after Coronavirus disease 2019
por: Kawabe, Ryoko, et al.
Publicado: (2022)

Eicosanoids: The Overlooked Storm in Coronavirus Disease 2019 (COVID-19)?
por: Hammock, Bruce D., et al.
Publicado: (2020)

Vitamin intervention for cytokine storm in the patients with coronavirus disease 2019
por: Kang, Jian‐Sheng
Publicado: (2020)

Cytokine storm with rapidly elevated interleukin-6 indicates sudden death in patients with critical COVID-19
por: Hu, Zhigang, et al.
Publicado: (2021)

Risk factors in blood for attacks of angina in patients with coronavirus disease 2019 and stable angina
por: Geng, Song, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ve3h8k5l5mj52d1smuinme9ced